LNTH Q2 2020 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q2 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$66M-23.0% YoY

Gross Profit

$26M39.2% margin

Operating Income

-$6M-8.4% margin

Net Income

-$7M-10.6% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-27.2%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$6M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$880M

Total Liabilities

$364M

Stockholders' Equity

$516M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$86M	-23.0%
Gross Profit	$26M	$45M	-42.0%
Operating Income	-$6M	$15M	-138.1%
Net Income	-$7M	$6M	-209.4%

Revenue Segments

US Segment

$57M87%

International Segment

$9M13%